Product Certification&
Enterprise Certification
Country: China (Mainland)
Business Type:Trading Company
Tel: +86-371- 86259723
Tel: 17734809689
Tel: 17734809689
Tel: 86-371-86259723
Tel: 17734809689
Tel: 17734809689
Mobile: 17734809689
Tel: +86-371- 86259723
Fax: +86-371- 86259723
Province/state: HENAN
City: ZHENGZHOU
Street: Mingmen International Center, NO.222 Dongming Road,Zhengzhou,Henan,China
MaxCard:
CAS NO.20099-89-2
HENAN SUNLAKE ENTERPRISE CORPORATION
Our company advantages:
1、The highest quality with the competitive price.
2、Professional human services.
3、The fastest and safest delivery service.
4、The faster and safest delivery service.
5、The high purity products.
6、We have a sufficient supply of stock.
7、A variety of payments, such as L/C, TT, , MoneyGram or other payments.
4-CYANOPHENACYL BROMIDE Basic information |
Product Name: | 4-CYANOPHENACYL BROMIDE |
Synonyms: | 4-(2-BROMOACETYL)BENZONITRILE;4-CYANOPHENACYL BROMIDE;4-(BROMOACETYL)BENZONITRILE;2-BROMO-4'-CYANOACETOPHENONE;BUTTPARK 41\03-55;cyanophenacylbromide;p-Bromoacetylbenzonitrile;4-Cyanophenacyl bromide 97% |
CAS: | 20099-89-2 |
MF: | C9H6BrNO |
MW: | 224.05 |
EINECS: | -0 |
Product Categories: | C8 to C9;Cyanides/Nitriles;Nitrogen Compounds;intermediates |
Mol File: | 20099-89-2.mol |
4-CYANOPHENACYL BROMIDE Chemical Properties |
Melting point | 92-96 °C(lit.) |
BRN | 2087648 |
CAS DataBase Reference | 20099-89-2(CAS DataBase Reference) |
Safety Information |
Hazard Codes | C |
Risk Statements | 20/21/22-34 |
Safety Statements | 26-27-36/37/39-45 |
RIDADR | UN 2928 6.1/PG 2 |
WGK Germany | 3 |
Hazard Note | Corrosive |
HazardClass | 6.1 |
PackingGroup | II |
MSDS Information |
Provider | Language |
---|---|
SigmaAldrich | English |
ACROS | English |
ALFA | English |
4-CYANOPHENACYL BROMIDE Usage And Synthesis |
Chemical Properties | off-white to light yellow crystalline powder |
Usage | 4-(2-Bromoacetyl)benzonitrile is useful for the irreversible inhibitory activity of Glycogen synthase kinase 3 (GSK-3). Phenylhalomethylketones can be used in the study of novel GSK-3 inhibitors. |